|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$3,880||Benefits minus costs||$21,023|
|Participants||$8,350||Benefit to cost ratio||$378.86|
|Others||$381||Chance the program will produce|
|Indirect||$8,467||benefits greater than the costs||100 %|
|Net program cost||($56)|
|Benefits minus cost||$21,023|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Smoking tobacco on a regular basis.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Regular smoking||Labor market earnings associated with smoking||$3,391||$7,964||$0||($1,695)||$9,660|
|Health care associated with smoking||$369||$104||$381||$185||$1,039|
|Mortality associated with smoking||$120||$282||$0||$10,006||$10,407|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($28)||($28)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$52||2014||Present value of net program costs (in 2018 dollars)||($56)|
|Comparison costs||$0||2014||Cost range (+ or -)||10 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Abroms, L.C., Boal, A.L., Simmens, S.J., Mendel, J.A., & Windsor, R.A. (2014). A randomized trial of Text2Quit: A text messaging program for smoking cessation. American Journal of Preventive Medicine, 47(3), 242-50.
Brendryen, H., Drozd, F., & Kraft, P. (2008). A digital smoking cessation program delivered through internet and cell phone without nicotine replacement (happy ending): Randomized controlled trial. Journal of Medical Internet Research, 10(5), e51.
Free, C., Whittaker, R., Knight, R., Abramsky, T., Rodgers, A., & Roberts, I.G. (2009). Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tobacco Control, 18 (2), 88-91.
Free, C., Knight, R., Robertson, S., Whittaker, R., Edwards, P., Zhou, W., Rodgers, A., Cairns, J., Kenward, M.G., & Roberts, I. (2011). Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet, 378 (9785), 49-55.
Haug, S., Meyer, C., Schorr, G., Bauer, S., & John, U. (2009). Continuous individual support of smoking cessation using text messaging: a pilot experimental study. Nicotine & Tobacco Research, 11 (8), 915-23.
Haug, S., Schaub, M.P., Venzin, V., Meyer, C., & John, U. (2013). Efficacy of a text message-based smoking cessation intervention for young people: a cluster randomized controlled trial. Journal of Medical Internet Research, 14 (809), 1-8.
Naughton, F., Prevost, A.T., Gilbert, H., & Sutton, S. (2012). Randomized controlled trial evaluation of a tailored leaflet and SMS text message self-help intervention for pregnant smokers (MiQuit). Nicotine & Tobacco Research, 14 (5), 569-577.
Rodgers, A., Corbett, T., Bramley, D., Riddell, T., Wills, M., Lin, R.B., & Jones, M. (2005). Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tobacco Control, 14 (4), 255-261.
Ybarra, M., Korchmaros, J., Bosi, A.T.B., & Emri, S. (2012). A text messaging-based smoking cessation program for adult smokers: Randomized controlled trial. Journal of Medical Internet Research, 14 (6), e172.